Nutriband Inc. (NASDAQ:NTRBW – Get Free Report)’s stock price was down 26.6% during mid-day trading on Friday . The company traded as low as $1.12 and last traded at $1.12. Approximately 99 shares were traded during mid-day trading, a decline of 95% from the average daily volume of 2,067 shares. The stock had previously closed at $1.5250.
Nutriband Stock Down 26.6%
The business has a 50 day simple moving average of $1.30 and a 200-day simple moving average of $1.48.
Hedge Funds Weigh In On Nutriband
An institutional investor recently bought a new position in Nutriband stock. Clear Street Group Inc. bought a new position in shares of Nutriband Inc. (NASDAQ:NTRBW – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 61,590 shares of the company’s stock, valued at approximately $105,000.
Nutriband Company Profile
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.
See Also
- Five stocks we like better than Nutriband
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
- Japan’s Stealth Bull Market: How U.S. Investors Can Get Exposure
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
